Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

• Status: COMPLETED
• Trial end date: 2025-03-19

Summary

Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial.

• Phase: PHASE3

Details

• Lead Sponsor: Materia Medica Holding